A Randomized, Repeat Dose, Open Label, Parallel Group, Multi-center Study to Evaluate the Effect of Daprodustat Compared to Darbepoetin Alfa on Forearm Blood Flow in Participants With Anemia of Chronic Kidney Disease That Are Not Dialysis Dependent
Not yet recruiting
Phase of Trial: Phase I/II
Latest Information Update: 17 Jan 2019
At a glance
- Drugs Daprodustat (Primary) ; Acetylcholine; Darbepoetin alfa; Sodium nitroprusside
- Indications Anaemia
- Focus Pharmacodynamics
- Acronyms FBF-CKD
- Sponsors GlaxoSmithKline
- 08 Jan 2019 Planned End Date changed from 2 Dec 2019 to 21 Jan 2020.
- 08 Jan 2019 Planned primary completion date changed from 2 Dec 2019 to 21 Jan 2020.
- 08 Jan 2019 Planned initiation date changed from 29 Oct 2018 to 15 Jan 2019.